Published in PLoS One on May 21, 2008
Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects. Malar J (2010) 2.73
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One (2008) 2.19
The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One (2011) 1.95
A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One (2011) 1.76
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS One (2010) 1.19
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial. PLoS One (2010) 1.14
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali. Trop Med Int Health (2009) 1.14
Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon. Malar J (2008) 1.10
Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa. Bull World Health Organ (2010) 1.09
Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants. PLoS One (2008) 1.04
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One (2010) 1.04
Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children. Malar J (2010) 0.93
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. Trans R Soc Trop Med Hyg (2009) 0.92
Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children. PLoS One (2011) 0.90
Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants. Malar J (2010) 0.87
Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy. Antimicrob Agents Chemother (2011) 0.80
Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. PLoS Med (2017) 0.79
Antimalarial drug resistance. J Clin Invest (2004) 8.50
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother (1997) 7.36
Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet (2001) 4.86
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ (2005) 3.87
Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet (2005) 3.79
The assessment of antimalarial drug efficacy. Trends Parasitol (2002) 3.38
A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis (2007) 3.38
Intermittent presumptive treatment for malaria. PLoS Med (2005) 3.36
Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis (2006) 3.17
Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet (2003) 2.36
Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg (1999) 2.35
Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health (2004) 2.28
A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One (2008) 2.24
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin Pharmacol Ther (2006) 2.18
The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today (1997) 2.07
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. J Infect Dis (2007) 1.99
Review: Intermittent preventive treatment--a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health (2006) 1.88
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana. Antimicrob Agents Chemother (2007) 1.82
How antimalarial drug resistance affects post-treatment prophylaxis. Malar J (2008) 1.80
Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. Trop Med Int Health (2004) 1.74
The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg (2003) 1.69
Clinical immunity to malaria. Curr Mol Med (2006) 1.63
Longevity of the immune response and memory to blood-stage malaria infection. Curr Top Microbiol Immunol (2005) 1.36
How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malar J (2007) 1.35
Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrob Agents Chemother (2005) 1.35
Effects of frailty in survival analysis. Stat Methods Med Res (1994) 1.33
Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? Trop Med Int Health (2007) 1.33
Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Trop Med Int Health (2008) 1.18
A randomized, comparative study of two regimens of beta-artemether for the treatment of uncomplicated, Plasmodium falciparum malaria, in northern Ghana. Ann Trop Med Parasitol (2004) 0.79
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis (2010) 7.42
Verbal autopsy: current practices and challenges. Bull World Health Organ (2006) 6.66
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Delayed breastfeeding initiation increases risk of neonatal mortality. Pediatrics (2006) 6.05
Use of clinical algorithms for diagnosing malaria. Trop Med Int Health (2002) 5.77
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet (2007) 5.11
Effect of the Newhints home-visits intervention on neonatal mortality rate and care practices in Ghana: a cluster randomised controlled trial. Lancet (2013) 4.80
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA (2005) 4.57
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ (2005) 3.87
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
From malaria control to eradication: The WHO perspective. Trop Med Int Health (2009) 3.85
Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. J Infect Dis (2005) 3.75
Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action (2012) 3.68
Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health (2006) 3.62
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J (2008) 3.42
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J (2007) 3.24
Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis (2008) 3.15
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Setting priorities in global child health research investments: universal challenges and conceptual framework. Croat Med J (2008) 2.93
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med (2004) 2.93
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One (2010) 2.90
A call to action for the new decade of vaccines. Lancet (2011) 2.72
Revising the WHO verbal autopsy instrument to facilitate routine cause-of-death monitoring. Glob Health Action (2013) 2.69
Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J (2009) 2.67
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Changing pattern of malaria in Bissau, Guinea Bissau. Trop Med Int Health (2008) 2.54
Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. Lancet (2010) 2.48
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands. Malar J (2008) 2.37
Core verbal autopsy procedures with comparative validation results from two countries. PLoS Med (2006) 2.36
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials (2006) 2.33
Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol (2013) 2.28
Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health (2004) 2.28
A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One (2008) 2.24
Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J (2006) 2.24
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet (2012) 2.21
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One (2008) 2.19
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One (2007) 2.17
Estimates of the burden of malaria morbidity in Africa in children under the age of 5 years. Trop Med Int Health (2008) 2.09
The changing and dynamic epidemiology of meningococcal disease. Vaccine (2011) 2.05
Quality along the continuum: a health facility assessment of intrapartum and postnatal care in Ghana. PLoS One (2013) 2.03
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One (2010) 2.03
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun (2007) 2.01
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet (2006) 2.00
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis (2013) 2.00
An epidemiological study of RSV infection in the Gambia. Bull World Health Organ (2002) 1.97
Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA (2013) 1.91
Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg (2006) 1.86
The need for new antibiotics. Lancet (2010) 1.85
Effect of early infant feeding practices on infection-specific neonatal mortality: an investigation of the causal links with observational data from rural Ghana. Am J Clin Nutr (2007) 1.82
Impact of free delivery care on health facility delivery and insurance coverage in Ghana's Brong Ahafo Region. PLoS One (2012) 1.79
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J (2008) 1.76
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One (2009) 1.73
Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? Malar J (2007) 1.72